Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour

NCT: NCT04011150 · ACTIVE_NOT_RECRUITING

NCT IDNCT04011150
StatusACTIVE_NOT_RECRUITING
Start Date2020-08-11
Completion2027-08-31
SponsorKK Women's and Children's Hospital (OTHER_GOV)
First posted
Last updated

Brief Summary

A novel epidural delivery regimen was developed: Variable volume automated mandatory bolus (AMB) (VVAMB) will advance individualisation of labour epidural analgesia, by which a larger volume of bolus may contribute to better spread of the local anaesthetics within brief period and thereby reduces the chances of motor blockade that could reduce instrumental deliveries.

Frequently Asked Questions

What is Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour?

Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour is a clinical trial registered under NCT04011150. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04011150?

The current status of NCT04011150 (Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour) is: ACTIVE_NOT_RECRUITING.

When did Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour start?

Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour started on 2020-08-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑